Home The Word Brain	My Amedeo FAQ Privacy About
	Explore this week’s CC Journal Club 90‑sec video • 4‑min audio • paper abstracts This week, 27 April 2025: Treatment-resistant hypertension Influenza transmission Nanoplastics in human brains Malaria elimination Chikungunya vaccine

Cytomegalovirus Infection

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 15 articles: HTML format

Single Articles

October 2024
1. ARMISTEAD B, Peters MQ, Houck J, Carlson M, et al
   Exposure to HIV is associated with altered composition of maternal microchimeric T cells in infants.
   J Infect Dis. 2024 Oct 22:jiae521. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2024
2. CHOU S, Winston DJ, Avery RK, Cordonnier C, et al
   Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection.
   J Infect Dis. 2024 Sep 20:jiae469. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2024
3. NAGELE K, Battig V, Gosert R, Walti CS, et al
   Revealing the unseen: next generation sequencing for early detection of drug-resistant cytomegalovirus variants upon letermovir prophylaxis failure.
   J Infect Dis. 2024 Aug 30:jiae414. doi: 10.1093.
   PubMed     Abstract available
   
   
   June 2024
4. MARCHANT A, Adali S, Alsdurf H, Bol V, et al
   Establishing correlates of maternal-fetal cytomegalovirus transmission-one step closer through predictive modeling.
   J Infect Dis. 2024 Jun 12:jiae281. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. STRIZKI JM, Diamond TL, Teal VL, Gilbert CL, et al
   Cytomegalovirus antiviral resistance among participants in the phase 3 trial of letermovir vs valganciclovir prophylaxis in kidney transplant recipients.
   J Infect Dis. 2024 Jun 10:jiae287. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2024
6. FIERRO C, Brune D, Shaw M, Schwartz H, et al
   Safety and Immunogenicity of a Messenger RNA-Based Cytomegalovirus Vaccine in Healthy Adults: Results From a Phase 1, Randomized, Clinical Trial.
   J Infect Dis. 2024 Mar 13:jiae114. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2024
7. HU X, Karthigeyan KP, Herbek S, Valencia SM, et al
   Human Cytomegalovirus mRNA-1647 Vaccine Candidate Elicits Potent and Broad Neutralization and Higher Antibody-Dependent Cellular Cytotoxicity Responses Than the gB/MF59 Vaccine.
   J Infect Dis. 2024 Feb 7:jiad593. doi: 10.1093.
   PubMed     Abstract available
   
   
   January 2024
8. VENTURINI C, Colston JM, Charles O, Lankina A, et al
   Persistent low-level variants in a subset of viral genes are highly predictive of poor outcome in immunocompromised patients with cytomegalovirus infection.
   J Infect Dis. 2024 Jan 5:jiae001. doi: 10.1093.
   PubMed     Abstract available
   
   
   September 2023
9. FERNANDEZ-RUIZ M, Garcia-Rios E, Redondo N, Rodriguez-Goncer I, et al
   Post-transplant dynamics and clinical significance of CMV-specific neutralizing antibodies in kidney transplant recipients treated with T-cell-depleting agents.
   J Infect Dis. 2023 Sep 22:jiad411. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. HUANG Y, Tang J, Yu H, Song Q, et al
    Reconsideration of maternal serological testing for predicting congenital CMV infection.
    J Infect Dis. 2023 Sep 21:jiad412. doi: 10.1093.
    PubMed     Abstract available
    
    
    
11. SADOWSKA-KLASA A, Leisenring WM, Limaye AP, Boeckh M, et al
    Cytomegalovirus Viral Load Threshold to Guide Preemptive Therapy in Hematopoietic Cell Transplant Recipients: Correlation with CMV Disease.
    J Infect Dis. 2023 Sep 8:jiad386. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2023
12. CHOU S, Alain S, Cervera C, Chemaly RF, et al
    Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
    J Infect Dis. 2023 Jul 28:jiad293. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2023
13. PARIS R, Apter D, Boppana S, D'Aloia M, et al
    Incidence of Cytomegalovirus Primary and Secondary Infection in Adolescent Girls: Results From a Prospective Study.
    J Infect Dis. 2023 Jun 21:jiad182. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2023
14. ALVAREZ-HEREDIA P, Reina-Alfonso I, Dominguez-Del Castillo JJ, Gutierrez-Gonzalez C, et al
    Accelerated T cell immunosenescence in CMV-seropositive individuals after SARS-CoV-2 infection.
    J Infect Dis. 2023 Apr 26:jiad119. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
15. HASTIE E, Moser C, Sun X, Lennox J, et al
    Effect of Immune-Modulatory Interventions on Asymptomatic Cytomegalovirus Shedding during Suppressive Antiretroviral Therapy.
    J Infect Dis. 2023 Mar 7:jiad060. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.